CCDC13-AS1

Across TCGA pan-cancer cohorts, CCDC13-AS1 RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of CCDC13-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CCDC13-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types CCDC13-AS1 is over-expressed in tumor, although a few such as KIRC and COAD show the opposite, repressed pattern.

KIRC, COAD, and KICH are the cancer types where CCDC13-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCDC13-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−0.929	<.001	11	view →
COAD	Female	All	−0.214	<.001	11	view →
KICH	Female	All	−1.201	<.001	10	view →
THCA	Male	III,IV	−1.338	<.001	9	view →
LUSC	Female	II,III,IV	−0.502	<.001	8	view →
LUAD	All	III,IV	−0.453	<.001	8	view →
UCEC	All	All	−0.504	.001	6	view →
BRCA	Female	All	−0.101	.009	4	view →
KIRP	All	III,IV	−0.667	.010	2	view →
PRAD	All	All	−0.301	<.001	2	view →
CHOL	All	All	+0.288	.007	2	view →
LIHC	All	All	+0.230	.020	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

CCDC13-AS1–KIRC

Open the KIRC breakdown →